Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells.
Michlewska S, Ionov M, Szwed A, Rogalska A, Sanz Del Olmo N, Ortega P, Denel M, Jacenik D, Shcharbin D, de la Mata FJ, Bryszewska M. Michlewska S, et al. Among authors: sanz del olmo n. Int J Mol Sci. 2020 Jun 9;21(11):4119. doi: 10.3390/ijms21114119. Int J Mol Sci. 2020. PMID: 32526993 Free PMC article.
Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR.
Carloni R, Sanz Del Olmo N, Ortega P, Fattori A, Gómez R, Ottaviani MF, García-Gallego S, Cangiotti M, de la Mata FJ. Carloni R, et al. Among authors: sanz del olmo n. Biomolecules. 2019 Sep 27;9(10):540. doi: 10.3390/biom9100540. Biomolecules. 2019. PMID: 31569790 Free PMC article.
Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An In Vitro Electron Paramagnetic Resonance Study.
Canonico B, Carloni R, Sanz Del Olmo N, Papa S, Nasoni MG, Fattori A, Cangiotti M, de la Mata FJ, Ottaviani MF, García-Gallego S. Canonico B, et al. Among authors: sanz del olmo n. Mol Pharm. 2020 Jul 6;17(7):2691-2702. doi: 10.1021/acs.molpharmaceut.0c00396. Epub 2020 Jun 15. Mol Pharm. 2020. PMID: 32484691
18 results